Medical Countermeasures Surveillance Integrated Program Team
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2012
|
|
Microbiological Testing of Live Biotherapeutic Products
|
Resource Development
|
FDA
|
NIAID
|
2012
|
|
Microphysiological Systems for Drug Efficacy and Toxicity Testing
|
Research Initiative
|
FDA
|
NCATS, NCI, NEI, NHLBI, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NINDS, NINR, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ OSC
|
2012
|
|
mPower Workgroup
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHLBI, NIA, NIBIB
|
2015
|
|
Multi-Agency Tissue Engineering Science (MATES) interagency working group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NEI, NHLBI, NIAMS, NIBIB, NICHD, NIDCR
|
2000
|
|
Multinational Influenza Seasonal Mortality Study (MISMS) Research
|
Research Initiative
|
FDA, OS
|
FIC, NHLBI, NIAID, NLM
|
2001
|
|
Muscular Dystrophy Coordinating Committee (MDCC)
|
Committee, Advisory Group, or Work Group
|
ACL, CDC, FDA, HRSA
|
NHLBI, NIAMS, NICHD, NINDS
|
2002
|
|